N. Bielsa, M. Casasampere, M. Aseeri et al.
European Journal of Medicinal Chemistry 216 (2021) 113296
D.J. Feith, T.P. Loughran, Ceramide analogue SACLAC modulates sphingolipid
levels and MCL-1 splicing to induce apoptosis in acute myeloid leukemia, Mol.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
[20] M. Kono, J.L. Dreier, J.M. Ellis, M.L. Allende, D.N. Kalkofen, K.M. Sanders,
J. Bielawski, A. Bielawska, Y.A. Hannun, R.L. Proia, Neutral ceramidase encoded
by the Asah2 gene is essential for the intestinal degradation of sphingolipids,
References
[21] M.V. Airola, W.J. Allen, M.J. Pulkoski-Gross, L.M. Obeid, R.C. Rizzo, Y.A. Hannun,
Structural basis for ceramide recognition and hydrolysis by human neutral
[22] S.A. Novgorodov, C.L. Riley, J. Yu, K.T. Borg, Y.A. Hannun, R.L. Proia, M.S. Kindy,
T.I. Gudz, Essential roles of neutral ceramidase and sphingosine in mito-
chondrial dysfunction due to traumatic brain injury, J. Biol. Chem. 289 (2014)
[1] S.F. Morad, M.C. Cabot, Ceramide-orchestrated signalling in cancer cells, Nat.
[2] M.A. Lone, T. Santos, I. Alecu, L.C. Silva, T. Hornemann, 1-Deoxysphingolipids,
Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864 (2019) 512e521, https://
[23] K. Sundaram, A.R. Mather, S. Marimuthu, P.P. Shah, A.J. Snider, L.M. Obeid,
Y.A. Hannun, L.J. Beverly, L.J. Siskind, Loss of neutral ceramidase protects cells
from nutrient and energy deprivation-induced cell death, Biochem. J. 473
[4] M. Casasampere, E. Izquierdo, J. Casas, J.L. Abad, X. Liu, R. Xu, C. Mao, Y.-
T. Chang, A. Delgado, G. Fabrias, Click and count: specific detection of acid
ceramidase activity in live cells, Chem. Sci. 11 (2020) 13044e13051, https://
[24] K. Tanaka, K. Tamiya-Koizumi, K. Hagiwara, H. Ito, A. Takagi, T. Kojima,
M. Suzuki, S. Iwaki, S. Fujii, M. Nakamura, Y. Banno, R. Kannagi, T. Tsurumi,
M. Kyogashima, T. Murate, Role of down-regulated neutral ceramidase during
all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuro-
[25] A.J. Snider, B.X. Wu, R.W. Jenkins, J.A. Sticca, T. Kawamori, Y.A. Hannun,
L.M. Obeid, Loss of neutral ceramidase increases inflammation in a mouse
model of inflammatory bowel disease, Prostag. Other Lipid Mediat. 99 (2012)
[26] Y. Osawa, H. Uchinami, J. Bielawski, R.F. Schwabe, Y.A. Hannun, D.A. Brenner,
Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepato-
[5] N. Coant, W. Sakamoto, C. Mao, Y.A. Hannun, Ceramidases, roles in sphingo-
lipid metabolism and in health and disease, Adv. Biol. Regul. 63 (2017)
[6] N. Shtraizent, E. Eliyahu, J.-H.H. Park, X. He, R. Shalgi, E.H. Schuchman,
Autoproteolytic cleavage and activation of human acid ceramidase, J. Biol.
[7] A. Gebai, A. Gorelik, Z. Li, K. Illes, B. Nagar, Structural basis for the activation of
acid ceramidase, Nat. Commun.
[8] F.P.S. Yu, S. Amintas, T. Levade, J.A. Medin, Acid ceramidase deficiency: Farber
cyte apoptosis in response to tumor necrosis factor-a, J. Biol. Chem. 280
ꢁ
[9] C. Bedia, J. Casas, N. Andrieu-Abadie, G. Fabrias, T. Levade, Acid ceramidase
[27] B.X. Wu, Y.H. Zeidan, Y.A. Hannun, Downregulation of neutral ceramidase by
gemcitabine: implications for cell cycle regulation, Biochim. Biophys. Acta
[28] M. Garcia-Barros, N. Coant, T. Kawamori, M. Wada, A.J. Snider, J.-P. Truman,
B.X. Wu, H. Furuya, C.J. Clarke, A.B. Bialkowska, A. Ghaleb, V.W. Yang,
L.M. Obeid, Y.A. Hannun, Role of neutral ceramidase in colon cancer, Faseb. J.
expression modulates the sensitivity of A375 melanoma cells to dacarbazine,
[10] N. Realini, F. Palese, D. Pizzirani, S. Pontis, A. Basit, A. Bach, A. Ganesan,
D. Piomelli, Acid ceramidase in melanoma: expression, localization and effects
of pharmacological inhibition, J. Biol. Chem. 291 (2016) 2422e2434, https://
[11] M. Lai, N. Realini, M. La Ferla, I. Passalacqua, G. Matteoli, A. Ganesan,
M. Pistello, C.M. Mazzanti, D. Piomelli, Complete Acid Ceramidase ablation
prevents cancer-initiating cell formation in melanoma cells, Sci. Rep. 7 (2017)
[12] J. Leclerc, D. Garandeau, C. Pandiani, C. Gaudel, K. Bille, N. Nottet, V. Garcia,
P. Colosetti, S. Pagnotta, P. Bahadoran, G. Tondeur, B. Mograbi, S. Dalle,
J. Caramel, T. Levade, R. Ballotti, N. Andrieu-Abadie, C. Bertolotto, Lysosomal
acid ceramidase ASAH1 controls the transition between invasive and prolif-
erative phenotype in melanoma cells, Oncogene 38 (2018) 1282e1295,
[13] X. Liu, J.C. Cheng, L.S. Turner, S. Elojeimy, T.H. Beckham, A. Bielawska,
T.E. Keane, Y.A. Hannun, J.S. Norris, Acid ceramidase upregulation in prostate
cancer: role in tumor development and implications for therapy, Expert Opin.
[29] N. Coant, M.G. Qifeng, Z. Lina, Y.A. Hannun, AKT as a key target for growth
promoting functions of neutral ceramidase in colon cancer cells, Oncogene 37
[30] W. Sun, R. Xu, W. Hu, J. Jin, H.A. Crellin, J. Bielawski, Z.M. Szulc, B.H. Thiers,
L.M. Obeid, C. Mao, Upregulation of the human alkaline ceramidase 1 and acid
ceramidase mediates calcium-induced differentiation of epidermal keratino-
ꢀ
[31] I. Vasiliauskaite-Brooks, R.D. Healey, P. Rochaix, J. Saint-Paul, R. Sounier,
C. Grison, T. Waltrich-Augusto, M. Fortier, F. Hoh, E.M. Saied, C. Arenz, S. Basu,
C. Leyrat, S. Granier, Structure of a human intramembrane ceramidase ex-
plains enzymatic dysfunction found in leukodystrophy, Nat. Commun.
9
Ther.
Targets
13
(2009)
1449e1458,
[32] S. Edvardson, J.K. Yi, C. Jalas, R. Xu, B.D. Webb, J. Snider, A. Fedick, E. Kleinman,
N.R. Treff, C. Mao, O. Elpeleg, Deficiency of the alkaline ceramidase ACER3
manifests in early childhood by progressive leukodystrophy, J. Med. Genet. 53
[33] Y. Yin, M. Xu, J. Gao, M. Li, Alkaline ceramidase 3 promotes growth of hepa-
tocellular carcinoma cells via regulating S1P/S1PR2/PI3K/AKT signaling,
[34] C. Chen, Y. Yin, C. Li, J. Chen, J. Xie, Z. Lu, M. Li, Y. Wang, C.C. Zhang, ACER3
supports development of acute myeloid leukemia, Biochem. Biophys. Res.
[35] W. Hu, R. Xu, W. Sun, Z.M. Szulc, J. Bielawski, L.M. Obeid, C. Mao, Alkaline
ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its
down-regulation inhibits both cell proliferation and apoptosis, J. Biol. Chem.
[14] T.H. Beckham, P. Lu, J.C. Cheng, D. Zhao, L.S. Turner, X. Zhang, S. Hoffman,
K.E. Armeson, A. Liu, T. Marrison, Y.A. Hannun, X. Liu, Acid ceramidase-
mediated production of sphingosine 1-phosphate promotes prostate cancer
invasion through upregulation of cathepsin B, Int. J. Canc. 131 (2012)
[15] L. Camacho, O. Meca-Cortes, J.L. Abad, S. Garcia, N. Rubio, A. Diaz, T. Celia-
Terrassa, F. Cingolani, R. Bermudo, P.L. Fernandez, J. Blanco, A. Delgado,
J. Casas, G. Fabrias, T.M. Thomson, Acid ceramidase as a therapeutic target in
[16] J.C. Cheng, A. Bai, T.H. Beckham, S.T. Marrison, C.L. Yount, K. Young, P. Lu,
A.M. Bartlett, B.X. Wu, B.J. Keane, K.E. Armeson, D.T. Marshall, T.E. Keane,
M.T. Smith, E.E. Jones, R.R.D. Jr, A. Bielawska, J.S. Norris, X. Liu, Radiation-
induced acid ceramidase confers prostate cancer resistance and tumor
[17] S.-F. Tan, X. Liu, T.E. Fox, B.M. Barth, A. Sharma, S.D. Turner, A. Awwad,
A. Dewey, K. Doi, B. Spitzer, M.V. Shah, S.A.F. Morad, D. Desai, S. Amin, J. Zhu,
J. Liao, J. Yun, M. Kester, D.F. Claxton, H.-G. Wang, M.C. Cabot, E.H. Schuchman,
R.L. Levine, D.J. Feith, T.P. Loughran, Acid ceramidase is upregulated in AML
and represents a novel therapeutic target, Oncotarget 7 (2016) 83208e83222,
[36] E.M. Saied, C. Arenz, Inhibitors of ceramidases, Chem. Phys. Lipids 197 (2016)
[37] Y. Otsuka, M.V. Airola, Y.-M. Choi, N. Coant, J. Snider, C. Cariello, E.M. Saied,
C. Arenz, T. Bannister, R. Rahaim, Y.A. Hannun, J. Shumate, L. Scampavia,
J.D. Haley, T.P. Spicer, Identification of small-molecule inhibitors of neutral
ceramidase (nCDase) via target-based high-throughput screening, SLAS dis-
cov,
Adv.
Sci.
Drug
Discov.
(2020),
[18] S.F. Tan, W. Dunton, X. Liu, T.E. Fox, S.A.F. Morad, D. Desai, K. Doi,
M.R. Conaway, S. Amin, D.F. Claxton, H.G. Wang, M. Kester, M.C. Cabot,
D.J. Feith, T.P. Loughran, Acid ceramidase promotes drug resistance in acute
[38] A. Bielawska, M.S. Greenberg, D. Perry, S. Jayadev, J.A. Shayman, C. McKay,
Y.A. Hannun, ( 1S, 2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol
as an inhibitor of ceramidase, J. Biol. Chem. 271 (1996) 12646e12654,
myeloid leukemia through NF-kB-dependent P-glycoprotein upregulation,
[19] J.M. Pearson, S.-F. Tan, A. Sharma, C. Annageldiyev, T.E. Fox, J.L. Abad,
G. Fabrias, D. Desai, S. Amin, H.-G. Wang, M.C. Cabot, D.F. Claxton, M. Kester,
[39] M. Raisova, G. Goltz, M. Bektas, A. Bielawska, C. Riebeling, A.M. Hossini,
9